Found 7 matching trials
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
PHASE2This trial aims to demonstrate the feasibility of this approach to reliably...
Location
AHN Cancer Institute - West Penn Hospital
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma
PHASE1Phase I Dose Escalation Study of CART19 Cells for Adult Patients With Relap...
Location
Institute of Hematology and Blood Transfusion, Czech Republic
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL
PHASE1The body has different ways of fighting infection and disease. No single wa...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
MT2017-45: CAR-T Cell Therapy for Heme Malignancies
PHASE2This is a phase II study of FDA-approved CAR-T products for patients with h...
Status
Active Not Recruiting
Location
Masonic Cancer Center at University of Minnesota
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
PHASE1This is an open-label, phase 1/2 study has the primary objective of decitab...
Status
Active Not Recruiting
Location
Biotherapeutic Department of Chinese PLA General Hospital
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
PHASE1This research study combines 2 different ways of fighting disease: antibodi...
Status
Active Not Recruiting
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch
N/AThis protocol for compassionate use combines 2 different ways of fighting d...
Status
No Longer Available
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill